26.03.2007 18:57:00
|
Humana Appoints Michael W. Fedyna Chief Actuary, Effective July 1, 2007
Humana Inc. (NYSE: HUM) announced today that effective July 1, 2007,
Michael (Mike) W. Fedyna, FSA, MAAA, will become the company’s
Chief Actuary. He will replace John M. Bertko, who will retire from
Humana on June 30, 2007.
Bertko will remain with the company through the completion of the 2008
Medicare bidding process, which culminates in the filing of proposed
2008 rates and benefits with the Centers for Medicare and Medicaid
Services in early June.
Fedyna was previously vice president and chief actuary for the New
York-based East Region of WellPoint, Inc., and was vice president and
chief actuary for WellChoice, Inc. prior to its acquisition by
WellPoint. He has had a wide range of experience, including serving as
the chief actuary and chief financial officer for various divisions of
CIGNA Corporation. He joined the company today to help ensure a smooth
transition, and will report to Humana’s Chief
Financial Officer, James H. Bloem.
Fedyna will be supported in his role by P. Anthony (Tony) Hammond, ASA,
MAAA, the company’s Vice President of Health
Services and Chief Medicare Actuary, reporting to Stefen F. Brueckner,
Vice President of Senior Products. Hammond has been with Humana for
seven years, focusing primarily on the company’s
Medicare products.
"Mike and Tony bring complementary leadership,
experience and expertise to an important area of Humana’s
operations,” said Michael B. McCallister, the
company’s president and chief executive
officer. "I’m
confident they will help us extend the growth we’ve
experienced over the past five years in all our business segments but
particularly in Medicare.”
Bertko joined Humana in 1999 and has led Humana’s
actuarial efforts as the company transformed itself into a
consumer-focused organization across its varied business segments. A
Fellow of the Society of Actuaries, he will leave the health benefits
industry to pursue a university-based teaching and policy analysis
career.
"John has made a meaningful contribution to
Humana across all our lines of business, but particularly as we
successfully undertook a major expansion of our Medicare offerings
following the passage of the Medicare Modernization Act of 2003,”
McCallister said. "With the filing of 2008
bids in June, the expansion’s all-important
first phase will be complete. We look forward at that time to wishing
John the best of success as he changes careers.” "I’ve had the
privilege to work on critical issues in health care financing and
delivery while at Humana over the last eight years, and hope that I’ve
made a contribution to a more efficient health care system in this
country,” Bertko said. "I
look forward to fulfilling a long-held dream of engaging in teaching and
research in a university setting.” About Humana
Humana Inc., headquartered in Louisville, Kentucky, is one of the nation’s
largest publicly traded health benefits companies, with more than 11
million medical members. Humana offers a diversified portfolio of health
insurance products and related services –
through traditional and consumer-choice plans –
to employer groups, government-sponsored plans, and individuals.
Over its 46-year history, Humana has consistently seized opportunities
to meet changing customer needs. Today, the company is a leader in
consumer engagement, providing guidance that leads to lower costs and a
better health plan experience throughout its diversified customer
portfolio.
More information regarding Humana is available to investors via the
Investor Relations page of the company’s web
site at http://www.humana.com,
including copies of:
Annual report to stockholders;
Securities and Exchange Commission filings;
Most recent investor conference presentation;
Quarterly earnings news releases;
Replays of most recent earnings release conference call;
Calendar of events (includes upcoming earnings conference call dates,
times, and access number, as well as planned interaction with research
analysts and institutional investors);
Corporate Governance Information.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Humana Inc.mehr Nachrichten
22.11.24 |
S&P 500-Titel Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 10 Jahren verdient (finanzen.at) | |
20.11.24 |
Börsianer in New York warten auf Impulse: S&P 500 notiert zum Ende des Mittwochshandels um seinen Schlusskurs vom Montag (finanzen.at) | |
20.11.24 |
Mittwochshandel in New York: S&P 500 fällt nachmittags zurück (finanzen.at) | |
20.11.24 |
Schwacher Handel: S&P 500 präsentiert sich mittags leichter (finanzen.at) | |
20.11.24 |
Verluste in New York: S&P 500 zeigt sich zum Start leichter (finanzen.at) | |
15.11.24 |
S&P 500-Papier Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 5 Jahren verloren (finanzen.at) | |
14.11.24 |
Schwache Performance in New York: S&P 500 zeigt sich zum Start des Donnerstagshandels leichter (finanzen.at) | |
08.11.24 |
S&P 500-Papier Humana-Aktie: So viel Verlust hätte ein Humana-Investment von vor 3 Jahren eingebracht (finanzen.at) |
Analysen zu Humana Inc.mehr Analysen
Aktien in diesem Artikel
Humana Inc. | 280,50 | -0,14% |
Indizes in diesem Artikel
S&P 500 | 5 998,74 | -0,38% |